TP53 and colorectal neoplasm: Reduction in ATR by siRNA or the inhibitor AZ-20, which has anti-colorectal tumor activity in vivo at 50 mg/kg per day [24], leads to increased etoposide-trapped Top2cc in both WT and these p53-deficient cells.